A Sign of the Times: Chi-Med’s MediPharma Steps Toward Independence

Accompanying the solid interim results announced by Hutchison China MediTech this week was an interesting indication of both the success of Chi-Med's Hutchison MediPharma R&D subsidiary and the evolution of the nascent biotech industry in China

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip